Non-stenotic fibro-calcific aortic valve as a predictor of myocardial infarction recurrence.
Myasoedova Veronika AChiesa MattiaCosentino NicolaBonomi AliceLudergnani MonicaBozzi MicheleValerio VincenzaMoschetta DonatoMassaiu IlariaMantegazza ValentinaMarenzi GiancarloPoggio PaoloPublished in: European journal of preventive cardiology (2024)
AVSc is a crucial variable for identifying AMI patients at high risk of recurrent AMI and its presence should be considered when assessing the management of AMI patients. The inclusion of AVSc in risk stratification models may improve the accuracy of predicting the likelihood of recurrent AMI, leading to more personalized treatment decisions.
Keyphrases
- acute myocardial infarction
- aortic valve
- end stage renal disease
- transcatheter aortic valve replacement
- ejection fraction
- aortic stenosis
- transcatheter aortic valve implantation
- left ventricular
- chronic kidney disease
- newly diagnosed
- heart failure
- peritoneal dialysis
- patient reported outcomes
- combination therapy
- acute coronary syndrome
- smoking cessation